Humana (HUM)
(Delayed Data from NYSE)
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Zacks News
UnitedHealth (UNH) Q1 Earnings to Gain From Optum Revenues
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings should see an upside from higher revenues in its health services segment named Optum.
Will UnitedHealth (UNH) Q1 Earnings Buoy on Revenue Growth?
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings should see an upside from revenue growth at both its segments - Optum and UnitedHealthcare.
Top Stock Reports for General Dynamics, Verizon & AIG
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Verizon Communications (VZ) and American International Group (AIG).
Humana (HUM) Shores Up Government Business With FPG Buyout
by Zacks Equity Research
Humana's (HUM) Medicare business is expected to benefit from its strategic acquisitions.
Check These 3 Health Insurers to Reap High Returns in Q2
by Zacks Equity Research
We streamline our search to three best insurance bets with potential to turn investors rich by garnering fat returns.
Medicare Rate Up More than Expected, Health Insurers to Gain
by Zacks Equity Research
Increase in Medicare Advantage reimburse rates bodes well for health insurers.
Walmart Takes on Amazon Again, Look What It's Done This Time
by Zacks Equity Research
Walmart (WMT) plans to introduce Walmart2World money transfer service in collaboration with MoneyGram International.
Can Walmart Fortify Position Against Amazon With Humana Deal?
by Zacks Equity Research
Walmart's (WMT) plans to extend existing ties with Humana to enhance healthcare offerings, seems another bullet shot by the former in its war against the e-commerce king.
5 Reasons Why Anthem (ANTM) is a Lucrative Investment Option
by Zacks Equity Research
Anthem (ANTM) appears an impressive investment option on the back of rising membership, favorable investment income as well as solid financial health.
Humana (HUM) Up 3.2% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Select Medical (SEM) Q4 Earnings Top Estimates, Keeps View
by Zacks Equity Research
Solid segmental performances aid Select Medical's (SEM) Q4 earnings.
Anthem Buys America's 1st Choice, Expands in Medicare Market
by Zacks Equity Research
Anthem's (ANTM) acquisition of America's 1st Choice falls in line with its strategy to expand in the Medicare Advantage market.
Ensign Group (ENSG) Beats on Q4 Earnings, Raises '18 View
by Zacks Equity Research
Ensign Group's (ENSG) top line rises in Q4 on solid segmental revenues.
Humana (HUM) Tops Q4 Earnings & Revenues, Issues '18 View
by Zacks Equity Research
Humana's (HUM) solid fourth-quarter results were driven by strong performance of Retail and Group & Specialty segments.
Humana???s (HUM) Q4 Earnings Surpass Expectations
by Anupama Mukhopadhyay
Humana's fourth quarter operating earnings of $2.06 per share surpassed the Zacks Consensus Estimate of $2.00.
Can Solid Retail Segment Drive Humana's (HUM) Q4 Earnings?
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to gain from solid premium growth, especially in the Retail segment.
Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem
by Zacks Equity Research
Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem
Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene
Disruptive Forces to Keep Health Insurers on Their Toes
by Zacks Equity Research
The year 2018 should be lined with continued policy changes and ongoing uncertainty for health insurers.
Zacks.com highlights: NETGEAR, Marathon Petroleum, Target, Humana and Hudbay Minerals
by Zacks Equity Research
Zacks.com highlights: NETGEAR, Marathon Petroleum, Target, Humana and Hudbay Minerals
CVS Health Grows in PBM With Rheumatoid Arthritis Program
by Zacks Equity Research
The new Transform Rheumatoid Arthritis Care program to help CVS Health (CVS) provide a personalized whole-patient support through specialty pharmacy and embedded AccordantCare nurses.
5 Stocks Riding High on Stellar Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
BD's CE Mark and Check-Point's Screening Test to Fight CPO
by Zacks Equity Research
BD (BDX)-Check-Points' advanced bacterial screening assay will help lower mortality rates caused by AMR.
4 Great Healthcare Stocks to Buy Ahead of Q4 Earnings
by Swarup Gupta
An ageing population and steady demand for healthcare services continue to make stocks from the sector a lucrative option.
UnitedHealth (UNH) Beats on Q4 Earnings, Revises 2018 View
by Zacks Equity Research
UnitedHealth (UNH) Q4 earnings reflect broad-based growth across both its segments.